ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy

▴ ReAlta Life Sciences Announces EMA Orphan Drug Designation for RLS-0071 for the Treatment of Neonatal Encephalopathy
The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European Union

ReAlta Life Sciences, Inc.,announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation to RLS-0071 (also known as PIC1-dPEG24) for the treatment of neonatal encephalopathy. This designation builds on the Orphan Drug Designation that ReAlta received from the U.S. Food and Drug Administration (FDA) Office of Orphan Drug Products earlier this year.

“There is an urgent need for new therapeutic options to treat hypoxic-ischemic encephalopathy, a devastating condition that has a profound impact on newborns and their families,” said Ulrich Thienel, M.D., Ph.D., ReAlta’s Chief Executive Officer. “ReAlta is committed to supporting this vulnerable population and bringing forward the first pharmacological therapy for the treatment of HIE. The Orphan Drug Designation is recognition that RLS-0071 may be an important therapeutic option for this rare but serious condition.”

The EMA grants orphan status to medicinal products intended to treat rare disorders that affect fewer than 5 people per 10,000 in the European Union (EU). The designation provides certain benefits to the drug developer, including ten years of market exclusivity upon marketing authorization, fee reductions, and scientific advice during clinical development.

ReAlta intends to submit an Investigational New Drug (IND) application to the FDA for HIE in 2021 and begin HIE Phase 2 studies in neonates in the U.S., followed by a clinical trial application (CTA) to the EMA in support of phase 2 studies in Europe.

Neonatal encephalopathy is also known as hypoxic ischemic encephalopathy (HIE) or neonatal brain asphyxia. In this disease, otherwise normal healthy infants suffer from oxygen starvation to the brain. This can be caused by several processes, including placental tear or tight cord around the neck. These infants are typically otherwise healthy, and the event is abrupt and unanticipated. Many of these infants will die after birth or suffer permanent, life-long brain damage, such as severe mental retardation, or cerebral palsy, or both. HIE is frequently emotionally and financially devastating for the families of HIE babies. Worldwide, HIE is among the top three causes of infant death. The current state-of-the-art treatment for HIE is therapeutic hypothermia; there are currently no pharmacological therapies approved for HIE.

Tags : #ReAltaLifeSciences #LatestNewsonReAltaLifeSciences4thDec #LatestPharmaNews4thDec #EuropeanMedicinesAgency #OxyzenStarvation

About the Author


Team Medicircle

Related Stories

03 Jan

China’s New Viral Menace: Is HMPV the Next COVID-19?

While HMPV may not have the same catastrophic impact as the coronavirus, its ability to cause severe respiratory illness in vulnerable populations should not be underestimated.

View
11 Mar

India’s Pharma and MedTech Sector Bolsters Self-Reliance Amidst Pandemic Challenges

India is poised to emerge as a global leader in pharmaceutical innovation and production, contributing significantly to healthcare resilience and sustainability on a global scale.

View
18 Nov

Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 Duty

The Madras High Court has not only rectified an apparent disparity but also championed the cause of fairness and equality. The ruling ensures that PG medicos, who played a crucial role in combating the COVID-19 pandemic, receive the recognition they deserve through the allocation of incentive marks.

View
28 Oct

Spike in Cases of Auto-Immune Disorders like Rheumatoid Arthritis Post-COVID

It looks like the Coronavirus infection has altered our immune system, leading to a variety of health problems like arthritis. Many Covid patients are now coming to us complaining of joint and body pain. We are especially seeing a rise in cases of rheumatoid arthritis among women between 30-50 years of age.

View
18 Feb

COVID increases the risk of diabetes, a study finds

Since the pandemic began, we have been hearing that people with comorbidities are at higher risk of contracting COVID infection because of low immunity. A recent study published in JAMA Network Open reveals that COVID-19 infection is associated with an increased risk of diabetes.

View
16 Feb

Mask made little or no difference in protecting against COVID-19, a study finds

A recent study, conducted by the UK-based Cochrane Review shows that wearing masks in the community probably made little or no difference in protecting against COVID-19.

View
23 Dec

All you need to know about BF7. COVID infection

Is covid over? Let us give you some insights on the BF7. COVID infection has hit India after China.

View
17 Dec

Are you protected with COVID VACCINE?

Are we fully protected from coronavirus this winter to prevent cold, and cough issues? Let us check out the details.

View
07 Dec

Are you protected with COVID VACCINE?

Are you protected with COVID VACCINE for the coronavirus infection? Let us check out some details about common coronavirus infections still occuring.

View
03 Aug

Precautionary measure for new deadly virus Zika

Along with coronavirus and monkeypox, our country is also under attack from the zika virus, as new cases arise. Here are some precautionary measures.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025